Droplet-based microfluidic platform for high-throughput screening of Streptomyces

Ran Tu,Yue Zhang,Erbing Hua,Likuan Bai,Huamei Huang,Kaiyue Yun,Meng Wang

DOI: https://doi.org/10.1038/s42003-021-02186-y

IF: 6.548

2021-05-31

Communications Biology

Abstract:Abstract Streptomyces are one of the most important industrial microorganisms for the production of proteins and small-molecule drugs. Previously reported flow cytometry-based screening methods can only screen spores or protoplasts released from mycelium, which do not represent the filamentous stationary phase Streptomyces used in industrial cultivation. Here we show a droplet-based microfluidic platform to facilitate more relevant, reliable and rapid screening of Streptomyces mycelium, and achieved an enrichment ratio of up to 334.2. Using this platform, we rapidly characterized a series of native and heterologous constitutive promoters in Streptomyces lividans 66 in droplets, and efficiently screened out a set of engineered promoter variants with desired strengths from two synthetic promoter libraries. We also successfully screened out several hyperproducers of cellulases from a random S. lividans 66 mutant library, which had 69.2–111.4% greater cellulase production than the wild type. Our method provides a fast, simple, and powerful solution for the industrial engineering and screening of Streptomyces in more industry-relevant conditions.

biology

What problem does this paper attempt to address?

The paper attempts to address the problem of more efficiently and accurately screening *Streptomyces* strains in an industrial fermentation environment. Traditional screening methods such as flow cytometry can only screen spores or protoplasts, which do not represent the filamentous *Streptomyces* used in industrial fermentation. Therefore, researchers have developed a new platform based on droplet microfluidics technology to achieve high-throughput screening of *Streptomyces* mycelia. This platform not only improves screening efficiency but also detects intracellular and extracellular signals at the single-cell level, thereby screening strains with enhanced production of specific metabolites or enzymes. Additionally, the platform can support the lifecycle of *Streptomyces* for up to 7 days, including germination, vegetative growth, secondary metabolism, and autolysis, better simulating the industrial fermentation environment. By optimizing parameters such as droplet size and flow rate, the platform achieved the screening of at least 10,000 variants per hour and demonstrated potential applications in screening different strength promoters and high-yield cellulase strains. In summary, this study aims to provide a fast, simple, and powerful solution for *Streptomyces* engineering and screening under conditions closer to industrial settings.